Diagnostic Classification on Melanoma zero-shot 1000
74.67F1-score (zero-shot)SlotVAE (k=2)
Evaluation results
| Method | Links | |
|---|---|---|
| SlotVAE (k=2)Superv. (%)=12026.05 | 74.67 | |
| DINOv2Superv. (%)=12026.05 | 69.47 | |
| DINOv2Superv. (%)=502026.05 | 68.7 | |
| DINOv2Superv. (%)=752026.05 | 67.73 | |
| DINOv2Superv. (%)=152026.05 | 67.3 | |
| DINOv2Superv. (%)=252026.05 | 66.6 | |
| SlotVAE (k=2)Superv. (%)=502026.05 | 66.6 | |
| SlotVAE (k=2)Superv. (%)=752026.05 | 66.23 | |
| SlotVAE (k=2)Superv. (%)=152026.05 | 64.03 | |
| SlotVAE (k=2)Superv. (%)=252026.05 | 64 | |
| RN+SA (k=2)Superv. (%)=502026.05 | 59.2 | |
| GlobalVAESuperv. (%)=752026.05 | 57.23 | |
| GlobalVAESuperv. (%)=502026.05 | 56.9 | |
| RN+SA (k=2)Superv. (%)=752026.05 | 56.83 | |
| GlobalVAESuperv. (%)=152026.05 | 56.2 | |
| RN+SA (k=2)Superv. (%)=252026.05 | 55.93 | |
| RN+SA (k=2)Superv. (%)=12026.05 | 54.73 | |
| RN+SA (k=2)Superv. (%)=152026.05 | 52.17 | |
| GlobalVAESuperv. (%)=252026.05 | 50.57 | |
| GlobalVAESuperv. (%)=12026.05 | 48.73 |